ABSTRACT. The cytoplasmic affinity of polymeric IgA for secretory component (SC) and the expression of joining (J) chain were examined in pokeweed mitogen (PWM)-stimulated human peripheral blood lymphocytes (PBL) to determine, on the ultrastructural level, the polymerization sites of human IgA. SC-binding was found in 5.7% of transformed PBL on day 7 of culture; SC-binding was observed in a high proportion of IgA-producing cells. A low proportion of IgM-producing cells also bound to SC, while there was virtually no SC-binding by strated that polymers are formed within IgA-producing cells before their selective transport into external secretions. Although the site of polymerization was not determined by morphological studies, biosynthetic studies revealed that IgA and IgM were polymerized shortly before, or at the time of secretion, and that J chain was required for polymerization in mouse myelomacells secreting IgA and IgM (1, 8, 15, 22, [27] [28] . However, the role of J chain in the polymerization of IgA and IgM has been questioned (9, ll, 16, 22); J chain was found not only in polymer-producing cells, but also in the cells that produce monomeric IgA, IgG, or IgD (4, [13] [14] [15] [22] [23] 36). Thus the actual function of J chain remains controversial.
Secretory immunoglobulin A (S-IgA), which plays important roles in the defense of mucosal surfaces, is composed of a secretory component (SC), joining (J) chain and two to four covalently linked molecules of monomeric IgA (for view, see ref. 22) . SC is a glycoprotein produced in the endoplasmic reticulum and perinuclear space of the epithelial cells of glandular tissues (5). SC is then directed to the basolateral membranes of epithelial cells and functions as a receptor for polymeric immunoglobulin (5, 22, 26) . J chain-containing polymeric IgA, synthesized and secreted by plasma cells, binds to SC on epithelial cell membranes, and is then internalized by pinocytosis and finally secreted into the glandular lumen in the form of S-IgA (5, 22).
It was proposed in the early reports (31, 35 ) that monomeric IgA produced by plasma cells is polymerized in the grandular epithelial cells by complexing with SC to form S-IgA. However, subsequent immunochemical studies of rabbit (19) and human S-IgA molecules (2), and of IgA released into the culture media from explants of secretory tissues or isolated cells from such tissues (for review, see ref. 22 ) convincingly demonstrated that polymers are formed within IgA-producing cells before their selective transport into external secretions. Although the site of polymerization was not determined by morphological studies, biosynthetic studies revealed that IgA and IgM were polymerized shortly before, or at the time of secretion, and that J chain was required for polymerization in mouse myelomacells secreting IgA and IgM (1, 8, 15, 22, [27] [28] . However, the role of J chain in the polymerization of IgA and IgM has been questioned (9, ll, 16, 22); J chain was found not only in polymer-producing cells, but also in the cells that produce monomeric IgA, IgG, or IgD (4, 13-15, 22-23, 36) . Thus the actual function of J chain remains controversial.
Free SCisolated from external secretions can combine in vitro with polymeric immunoglobulins (20, 22, 29) . Applying this principle to tissue sections, Brandtzaeg (3, 6) and Radl et al. (30) found that J chain-producing IgA and IgMimmunocytes in various mucosa-associated tissues and glands can express cytoplasmic affinity for SC (SC-binding test), and showed that immunocytes producing monomer or polymer forms can be distinguished in such tissues by the paired immunofluorescence method. Although it has been described that polymerization of IgM occurs in the endoplasmic reticulum of IgM-secreting murine plasmablasts examined by a combination of pulsechase protocols, subcellular fractionation and electron microscopic autoradiography (34), the polymerization site of human IgA has not been conclusively determined at the ultrastructural level.
Thus, in this study we have examined the relationship between J chain expression and polymer production, using the SC-binding test in transformed human peripheral blood lymphocytes (PBL) stimulated with pokeweed mitogen (PWM). Furthermore, the sites where the polymerization of human IgA and the addition of J chain occur were determined by means of immunoelectron microscopy.
MATERIALS AND METHODS
Tissue culture and cell processing. The peripheral blood used in these studies was obtained from healthy young university students of both sexes. Mononuclear cells were isolated by centrifugation on a Ficoll-Hypaque density gradient. After the removal of monocytes by adherence to plastic dishes, the remaining cells were cultured at a concentration of 1.0 x 106/ml of RPMI 1640 medium, supplemented with 20% fetal bovine serum (Gibco Co., Grand Island, NY) and 50 jug/ml gentamicin (Schering Corp., Kenilworth, NJ), in the presence of 0.1 ml PWM/ml culture medium. Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO2 in air. Cytocentrifuge slides of cultured cells were fixed for 10 min in 95% ethanol containing 5% acetic acid, and after extensive washing in phosphate (0.01 M)-buffered saline (0.15 M) pH 7.2 (PBS), the slides were used for immunofluorescent staining. The remaining cells were processed for immunoelectron microscopic staining.
SC purification and SC-binding test. SC was purified from human colostrum according to previously published methods (21 Immunoelectron microscopic procedures. To determine the localization of SC-binding sites in transformed PBL, cultured cells were initially fixed in periodate-lysine-2% paraformaldehyde (PLP) for 30 min at room temperature and then resuspended in PBS. FiftyjA of fixed cells at a concentration of 4 x 106 cells/ml were transferred in a cytocentrifuge onto glass slides coated with 0.01% poly-1-lysine and were dried for 2 hr at 4°C. After extensive washing with PBS, the cells were incubated with normal rabbit serum for 20 min and then with SC for 6 hr. After washing, horseradish peroxidase (HRP)-labeled F(ab')2 fragments of anti-human SC were added for 6 hr. Specimens were immersed for 25 min in 3,3' diaminobenzidine tetrahydrochloride (DAB) solution without H2 O2, and subsequently in DABsolution containing 0.005% H2 O2 for 5 min (12) . The cells were extensively washed, fixed in 2.5% glutaraldehyde and \% OSO4 fixatives, dehydrated in graded ethanol and embedded in Spurr's resin (32). Localization of SC-binding sites in the humansmall intestine was determined using the method described by Nagura et al. (26) . In brief, a histochemically normal small intestine obtained from a patient with stomach carcinoma was divided into small pieces by means of a razor blade. Such samples were fixed in 4% PLP for 6 hr at 4°C, washed successively with PBS containing 10, 15, and 20% sucrose, and then embedded in OCT under the same conditions. Localization of both SC-binding sites and J chain in a single cell was examined similarly; after immunoelectron microscopic staining for the SC-binding test and DAB reaction, cells were incubated with rabbit antihuman J chain followed by biotinylated anti-rabbit IgG (Vector) and then with avidin-labeled ferritin (Vector). Omission of biotinylated anti-human IgA, avidin-labeled ferritin, antihuman J chain, or biotinylated anti-rabbit IgG, were used as controls. In addition, non-immunehumanIgG was used as a control for all experiments.
RESULTS

SC-binding
in PWM-stimulated blood lymphocytes. There were no cells that displayed cytoplasmic affinity for SC among unstimulated peripheral blood lymphocytes in the 8 cases examined. However, after PWM stimulation, two patterns of cytoplasmic affinity for SC were observed by immunofluorescence: one exhibited diffusely stained cytoplasm, and the other showed a spotlike staining which probably corresponded to the Golgi area. A few SC-binding cells appeared on days 3-4 of culture after PWMstimulation. The number of positive cells increased gradually day by day and reached a plateau at days 6-7 of culture. The in- Table I . Cytoplasmic SC-binding and J chain positivity in PWM-stimulated peripheral blood lymphocytes (7 day cultures).
PWM,Pokeweed mitogen; SC, Secretory component; B, Binding; Ig, Immunoglobulin; J, J chain. crease in SC-binding cells paralleled the increase in immunoglobulin-producing cells, and on day 7 approximately 5.7% of total cells showed cytoplasmic affinity for SC. Only IgA-and IgM-producing cells had a cytoplasmic affinity for SC; SC-binding was detected in approximately 78.5% of IgA-and 24.8% of IgM-producing cells. SC-binding was not detected in IgG-producing cells at this time except for in one of the 8 samples examined. In this case, SC-binding was found in approximately 7.1% of IgG-producing cells (Table I) (Fig. 1) . SC-binding sites, including the perinuclear space and endoplasmic reticulum, were detected in plasma cells infiltrating in the lamina propria of a human small intestine (Fig. 2) . No endogenous SC was detected in plasma cells of any control sections, while it was found in the perinuclear space, endoplasmic reticulum, small vesicles and basolateral membrane of epithelial cells when HRP-labeled anti-human SC was used.
By double immunoelectron microscopy with SC and HRP-labeled anti-SC, and ferritin-labeled anti-IgA, coincidental localizations of SC and IgA were observed. SC-binding sites and IgA were found in the perinuclear space and endoplasmic reticulum of transformed peripheral blood lymphocytes (Fig. 3) . Some ferritin particles indicating the presence of IgA were observed in electron-lucent areas of the endoplasmicreticulum and also in the SC-binding areas (Fig. 3, insert) . These findings suggest that both polymeric as well as monomeric IgA may have been present in this area. J chain was found in the perinuclear space and endoplasmic reticulum of PWM-stimulated PBL (Fig. 4) . Coincidental localizations of SC-binding sites and J chain were observed in the perinuclear space and endoplasmic reticulum within a single transformed peripheral blood lymphocyte by double immunoelectron microscopy (Fig. 5) . HRPand ferritin that were not linked with antibody did not bind to transformed PBL used as con- {Received for publication, November 14, 1989 and in revised form, February 27, 1990) 
